204 related articles for article (PubMed ID: 10353490)
1. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.
Li J; Daughters RS; Bullis C; Bengiamin R; Stucky MW; Brennan J; Simone DA
Pain; 1999 May; 81(1-2):25-33. PubMed ID: 10353490
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
[TBL] [Abstract][Full Text] [Related]
3. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
4. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats.
Gilchrist HD; Allard BL; Simone DA
Pain; 1996 Sep; 67(1):179-188. PubMed ID: 8895246
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
Potenzieri C; Harding-Rose C; Simone DA
Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
[TBL] [Abstract][Full Text] [Related]
6. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
7. NK-1 receptors in the rostral ventromedial medulla contribute to hyperalgesia produced by intraplantar injection of capsaicin.
Pacharinsak C; Khasabov SG; Beitz AJ; Simone DA
Pain; 2008 Sep; 139(1):34-46. PubMed ID: 18407414
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
9. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.
Tsou K; Lowitz KA; Hohmann AG; Martin WJ; Hathaway CB; Bereiter DA; Walker JM
Neuroscience; 1996 Feb; 70(3):791-8. PubMed ID: 10627219
[TBL] [Abstract][Full Text] [Related]
10. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
[TBL] [Abstract][Full Text] [Related]
11. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.
Herzberg U; Eliav E; Bennett GJ; Kopin IJ
Neurosci Lett; 1997 Jan; 221(2-3):157-60. PubMed ID: 9121688
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons.
Johanek LM; Simone DA
J Neurophysiol; 2005 Feb; 93(2):989-97. PubMed ID: 15385593
[TBL] [Abstract][Full Text] [Related]
13. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
14. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
Fox A; Kesingland A; Gentry C; McNair K; Patel S; Urban L; James I
Pain; 2001 May; 92(1-2):91-100. PubMed ID: 11323130
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway.
Anderson LA; Anderson JJ; Chase TN; Walters JR
Brain Res; 1995 Sep; 691(1-2):106-14. PubMed ID: 8590042
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.
Lever IJ; Pheby TM; Rice AS
Br J Pharmacol; 2007 May; 151(2):292-302. PubMed ID: 17375083
[TBL] [Abstract][Full Text] [Related]
17. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
18. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
19. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.
Martin WJ; Hohmann AG; Walker JM
J Neurosci; 1996 Oct; 16(20):6601-11. PubMed ID: 8815936
[TBL] [Abstract][Full Text] [Related]
20. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
